微创胰腺切除术后并发症的腹腔镜再手术价值探讨
结论认为腹腔镜再手术可用于非危及生命的指征,尤其是远端胰腺切除术后胰瘘引流或胰十二指肠切除术后肠梗阻。
要点
- 微创胰腺切除后再手术率8.7%,中位再手术时间9天(IQR 4-19天)。
- 再手术主要原因为出血(46%)和胰瘘伴失控感染(23%)。
- 腹腔镜再手术多用于胰瘘引流(43%)、出血(26%)、肠梗阻(20%)和腹膜炎(8%)。
核心结论
- 腹腔镜再手术可作为微创胰腺切除术后非危及生命并发症的一种选择。
- 腹腔镜再手术与更短住院时间和经加权调整后更低的术后死亡率相关。
研究设计与样本
- 基于法国AFC多中心队列(2010-2021年)的回顾性比较研究。
- 纳入微创胰腺切除术后90天内再手术的患者,比较开放再手术组与腹腔镜再手术组。
- 采用逆概率处理加权(IPTW)分析评估腹腔镜再手术对术后死亡率的影响。
主要发现
- 再手术中位延迟9天(IQR 4-19天),最常见原因为术后胰瘘伴失控感染(23%)和出血(46%)。
- 再手术后总体术后死亡率为13%。
临床怎么用
- 对于微创胰腺切除术后非危及生命的并发症,可考虑腹腔镜再手术。
- 远端胰腺切除术后胰瘘引流或胰十二指肠切除术后肠梗阻是腹腔镜再手术的常见适用场景。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Although the use of the minimally invasive approach is expanding in pancreatic surgery, indications and results of laparoscopic reinterventions after pancreatectomy are unknown. METHODS: Based on the multicenter AFC (Association Française de Chirurgie) cohort (2010-2021), patients who underwent open (open reoperation group) or laparoscopic (laparoscopic reoperation group) reoperation within 90 days after minimally invasive pancreatectomy were included and compared. Inverse probability of treatment weighting analysis was performed to determine the impact of laparoscopic reoperation on postoperative mortality. RESULTS: Of the 3,412 patients who underwent minimally invasive pancreatectomy, 298 (8.7%) underwent reoperation, with a median delay of 9 days (interquartile range: 4-19 days). Most frequent causes of reintervention were pancreatic fistula with uncontrolled sepsis (postoperative pancreatic fistula) (23%) and hemorrhage (postpancreatectomy hemorrhage) (46%). Sixty-five patients (22%) underwent laparoscopic and 233 (78%) open reoperation. Laparoscopic reoperation was mostly performed for postoperative pancreatic fistula drainage (43%), postpancreatectomy hemorrhage (26%), bowel obstruction (20%), or peritonitis (8%). Patients in the laparoscopic reoperation group were more often reoperated on after distal pancreatectomy (54% vs 36% in open reoperation group, P = .017). After pancreatoduodenectomy, laparoscopic reoperation was more often performed for bowel obstruction compared with open reoperation (20% vs 4%, P = .005). After reintervention, the postoperative mortality rate was 13%. Hospital stay was significantly shorter after laparoscopic reoperation (28 vs 36 days, P = .037). After adjustment for inverse probability of treatment weighting, laparoscopic revision was statistically associated with less postoperative mortality (odds ratio = 0.81, 95% confidence interval: 0.81-0.95). CONCLUSION: The laparoscopic approach may be an option for surgical reintervention after minimal invasive pancreatectomy in non-life-threatening indications, mainly after distal pancreatectomy for postoperative pancreatic fistula drainage or after pancreatoduodenectomy for occlusion.
引用
- Nassar A, De Ponthaud C, Tzedakis S, et al. Is there a place for laparoscopic reoperation for complications after minimally invasive pancreatectomy? Surgery. 2025. PMID: 40403477. doi:10.1016/j.surg.2025.109413
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。